03/18/2024
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
4:28 PM | Allogene Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024
4:21 PM | Allogene Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2024
3:51 PM | Allogene Therapeutics (Filer)
| Form POSASR | |
03/14/2024
3:55 PM | Allogene Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
3:31 PM | Allogene Therapeutics (Subject)
Chang David D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
8:52 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/16/2024
7:30 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Allogene Therapeutics (Subject)
Belldegrun Arie (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
4:45 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:46 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:47 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:48 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:51 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:42 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | Allogene Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
4:25 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
9:02 AM | Allogene Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
3:11 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:00 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:26 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
2:46 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:17 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:41 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
10/25/2023
4:29 PM | Allogene Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13D/A | |
10/17/2023
3:34 PM | Allogene Therapeutics (Filer)
| Form 8-K/A | |
10/16/2023
6:25 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
7:31 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
5:57 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
1:50 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
6:59 PM | Allogene Therapeutics (Issuer)
CHEN YINLIN JACK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:28 PM | Allogene Therapeutics (Issuer)
CHEN YINLIN JACK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
3:04 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
9:20 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
06/29/2023
1:08 PM | Allogene Therapeutics (Subject)
Bhavnagri Veer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
3:05 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:37 PM | Allogene Therapeutics (Subject)
Bhavnagri Veer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
4:02 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:03 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:06 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Secret Bull Market Starts in This Unusual Sector (Ad) "We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come."
In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.  Click for my No. 1 investment, all free of charge, click here. |
06/14/2023
7:04 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:08 PM | Allogene Therapeutics (Subject)
MOORE ALISON (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2023
4:17 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/26/2023
4:20 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
3:09 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/24/2023
3:11 PM | Allogene Therapeutics (Filer)
| Form ARS | |
